Starling Oncology TOI
TOI
$6.20 +0.01 (+0.16%)
At close: Aug 11, 2026 · 4:00 PM EDT

Oncology Institute, Inc. (TOI) Acquisitions (2021 - 2023)

Oncology Institute's (TOI) quarterly Acquisitions came in at $156000.0 in Q4 2023, down 66.81% YoY from $470000.0 in Q4 2022, and down 66.81% on a QoQ basis from $470000.0 in Q4 2022.

Oncology Institute, Inc. (TOI) Acquisitions (2021 - 2023) Analysis & Trends

Oncology Institute (TOI) has 3 years of Acquisitions data on file, last reported at $156000.0 in Q4 2023.

  • Quarterly Acquisitions fell 66.81% year-over-year to $156000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2024 was $156000.0 (up 183.42% YoY) and the FY2023 annual result came in at $4.5 million, down 48.05% from the prior year.
  • Acquisitions fell to $156000.0 in Q4 2023, from $470000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $8.9 million in Q2 2022 to a low of -$813000.0 in Q3 2022.
  • A 3-year average of $3.0 million and a median of $648500.0 in 2021 frame the typical range for Acquisitions.
  • Annual changes were most pronounced in 2022 — Acquisitions tumbled 94.32% — and 2023, when it sank 66.81%.
  • Tracing TOI's Acquisitions over 3 years: stood at $8.3 million in 2021, then plunged by 94.32% to $470000.0 in 2022, then slumped by 66.81% to $156000.0 in 2023.
  • The last three Acquisitions figures came in at $156000.0 (Q4 2023), $470000.0 (Q4 2022), and -$813000.0 (Q3 2022), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2023 156,000.00
Dec 31, 2022 470,000.00
Sep 30, 2022 -813,000.00
Jun 30, 2022 8.92 Mn
Dec 31, 2021 8.28 Mn
Mar 31, 2021 827,000.00